CreakyJoints Finds Lack of Research Stymies Uptake of Evidenced Based Prescribing of Medical Marijuana for Pain Associated with Rheumatic Conditions

CreakyJoints Finds Lack of Research Stymies Uptake of Evidenced Based Prescribing of Medical Marijuana for Pain Associated with Rheumatic Conditions
CANNANNEW REPORT

Differing State Laws Are Barriers to Providers and Patients Accessing Potential Therapy for Pain UPPER NYACK, N.Y.–(BUSINESS WIRE)–#ArthritisPower–A new review article from CreakyJoints, the international digital community for millions of arthritis patients and caregivers who seek education, support, advocacy, and patient-centered research, finds that there has been limited progress in understanding the potential of cannabis based therapies for the treatment of pain associated with rheumatic conditions in the past five years because of a lack of standardization of clinical research and barriers to conducting research due to existing federal and state regulations. The article, “Cannabis for rheumatic disease pain: A review of current literature,” published in the latest issue of Current Rheumatology Reports. The review found that legalization and decriminalization of cannabis at the state level reflects and promotes changing attitudes about cannabis corresponding to its increased use across a broad range of conditions, including rheumatic diseases. In addition, over 90 percent of Americans overall now support legal use of medicinal marijuana. Unfortunately, while there is strong, preclinical (animal) evidence showing that cannabis-based products play a role in alleviating pain and reducing inflammation, the highly variable state and federal statutes have limited patient-centered prospective research, education of clinicians, and comfort of patients in disclosing use of these therapies to their clinicians. “In 2019, CreakyJoints presented data from our ArthritisPower Research Registry study showing more than half of arthritis patients reported wanting information on or actually had tried marijuana and/or cannabidiol products for a purpose they perceived as medical (often for pain relief and help sleeping) and yet, three years later, there’s been virtually no advancement in the research necessary to provide clinical evidence that rheumatologists and patients need to make decisions about cannabis use for symptom relief in combination with approved treatments,” said W. Benjamin Nowell, PhD, Director, Patient-Centered Research…

Excerpt only …
READ MORE BELOW
Source : CreakyJoints Finds Lack of Research Stymies Uptake of Evidenced Based Prescribing of Medical Marijuana for Pain Associated with Rheumatic Conditions

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.